Thank you.
The committee heard from Dr. Craig Campbell, from his department of pediatrics and neurology at the Children's Hospital at the London Health Sciences Centre, that registries are essential to capturing data on the health benefits and risks of new drugs on rare diseases.
Can you describe what additional steps Health Canada could take to support the surveillance of the safety and efficacy of a drug that could be more effective?
Dr. MacKenzie.